229 related articles for article (PubMed ID: 11719453)
21. Maturation of dendritic cells in the presence of living, apoptotic and necrotic tumour cells derived from squamous cell carcinoma of head and neck.
Kacani L; Wurm M; Schwentner I; Andrle J; Schennach H; Sprinzl GM
Oral Oncol; 2005 Jan; 41(1):17-24. PubMed ID: 15598581
[TBL] [Abstract][Full Text] [Related]
22. IL-15-induced human DC efficiently prime melanoma-specific naive CD8+ T cells to differentiate into CTL.
Dubsky P; Saito H; Leogier M; Dantin C; Connolly JE; Banchereau J; Palucka AK
Eur J Immunol; 2007 Jun; 37(6):1678-90. PubMed ID: 17492620
[TBL] [Abstract][Full Text] [Related]
23. Apoptosis of monocytes and the influence on yield of monocyte-derived dendritic cells.
Bohnenkamp HR; Burchell JM; Taylor-Papadimitriou J; Noll T
J Immunol Methods; 2004 Nov; 294(1-2):67-80. PubMed ID: 15604017
[TBL] [Abstract][Full Text] [Related]
24. Enhanced T-cell activation by immature dendritic cells loaded with HSP70-expressing heat-killed melanoma cells.
Knudsen S; Schardt A; Buhl T; Boeckmann L; Schön MP; Neumann C; Haenssle HA
Exp Dermatol; 2010 Feb; 19(2):108-16. PubMed ID: 19758341
[TBL] [Abstract][Full Text] [Related]
25. Differentiation of immunostimulatory stem-cell- and monocyte-derived dendritic cells involves maturation of intracellular compartments responsible for antigen presentation and secretion.
Bykovskaia SN; Shurin GV; Graner S; Bunker ML; Olson W; Thomas R; Shurin MR; Marks S; Storkus WJ; Shogan J
Stem Cells; 2002; 20(5):380-93. PubMed ID: 12351809
[TBL] [Abstract][Full Text] [Related]
26. Induction of cytotoxic T lymphocytes against human cancer cell lines using dendritic cell-tumor cell hybrids generated by a newly developed electrofusion technique.
Imura K; Ueda Y; Hayashi T; Itoh T; Shimizu K; Tamai H; Yano Y; Naito K; Kohara J; Nakane K; Matsuura Y; Takeda A; Takeda T; Kawai K; Yamagishi H
Int J Oncol; 2006 Sep; 29(3):531-9. PubMed ID: 16865268
[TBL] [Abstract][Full Text] [Related]
27. Dendritic cells stimulated with a bacterial product, OK-432, efficiently induce cytotoxic T lymphocytes specific to tumor rejection peptide.
Nakahara S; Tsunoda T; Baba T; Asabe S; Tahara H
Cancer Res; 2003 Jul; 63(14):4112-8. PubMed ID: 12874015
[TBL] [Abstract][Full Text] [Related]
28. Impact of transfection with total RNA of K562 cells upon antigen presenting, maturation, and function of human dendritic cells from peripheral blood mononuclear cells.
Gao L; Fan HH; Lu HZ; Nie XX; Liu Y; Yang YM; Qian KC; Gao F
Transfusion; 2007 Feb; 47(2):256-65. PubMed ID: 17302772
[TBL] [Abstract][Full Text] [Related]
29. Cytotoxic T cell responses against mesothelioma by apoptotic cell-pulsed dendritic cells.
Ebstein F; Sapede C; Royer PJ; Marcq M; Ligeza-Poisson C; Barbieux I; Cellerin L; Dabouis G; Grégoire M
Am J Respir Crit Care Med; 2004 Jun; 169(12):1322-30. PubMed ID: 15070823
[TBL] [Abstract][Full Text] [Related]
30. Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.
Galea-Lauri J; Wells JW; Darling D; Harrison P; Farzaneh F
Cancer Immunol Immunother; 2004 Nov; 53(11):963-77. PubMed ID: 15146294
[TBL] [Abstract][Full Text] [Related]
31. Efficient activation of autologous tumor-specific T cells: a simple coculture technique of autologous dendritic cells compared to established cell fusion strategies in primary human colorectal carcinoma.
Draube A; Beyer M; Schumer S; Thomas RK; von Tresckow B; Koslowsky TC; Krieglstein CF; Schultze JL; Wolf J
J Immunother; 2007; 30(4):359-69. PubMed ID: 17457211
[TBL] [Abstract][Full Text] [Related]
32. Interferon gamma stimulates cellular maturation of dendritic cell line DC2.4 leading to induction of efficient cytotoxic T cell responses and antitumor immunity.
He T; Tang C; Xu S; Moyana T; Xiang J
Cell Mol Immunol; 2007 Apr; 4(2):105-11. PubMed ID: 17484804
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of dendritic cell maturation by malaria is dose dependent and does not require Plasmodium falciparum erythrocyte membrane protein 1.
Elliott SR; Spurck TP; Dodin JM; Maier AG; Voss TS; Yosaatmadja F; Payne PD; McFadden GI; Cowman AF; Rogerson SJ; Schofield L; Brown GV
Infect Immun; 2007 Jul; 75(7):3621-32. PubMed ID: 17470539
[TBL] [Abstract][Full Text] [Related]
34. Differential responses of cord and adult blood-derived dendritic cells to dying cells.
Wong OH; Huang FP; Chiang AK
Immunology; 2005 Sep; 116(1):13-20. PubMed ID: 16108813
[TBL] [Abstract][Full Text] [Related]
35. Induction of cytolytic T lymphocytes against pediatric solid tumors in vitro using autologous dendritic cells pulsed with necrotic primary tumor.
Shilyansky J; Jacobs P; Doffek K; Sugg SL
J Pediatr Surg; 2007 Jan; 42(1):54-61; discussion 61. PubMed ID: 17208541
[TBL] [Abstract][Full Text] [Related]
36. FastDC derived from human monocytes within 48 h effectively prime tumor antigen-specific cytotoxic T cells.
Dauer M; Schad K; Herten J; Junkmann J; Bauer C; Kiefl R; Endres S; Eigler A
J Immunol Methods; 2005 Jul; 302(1-2):145-55. PubMed ID: 15992809
[TBL] [Abstract][Full Text] [Related]
37. Antitumour necrosis factor-alpha chimeric antibody (infliximab) inhibits activation of skin-homing CD4+ and CD8+ T lymphocytes and impairs dendritic cell function.
Bedini C; Nasorri F; Girolomoni G; Pità Od; Cavani A
Br J Dermatol; 2007 Aug; 157(2):249-58. PubMed ID: 17489975
[TBL] [Abstract][Full Text] [Related]
38. Heat-shock induction of tumor-derived danger signals mediates rapid monocyte differentiation into clinically effective dendritic cells.
Aguilera R; Saffie C; Tittarelli A; González FE; Ramírez M; Reyes D; Pereda C; Hevia D; García T; Salazar L; Ferreira A; Hermoso M; Mendoza-Naranjo A; Ferrada C; Garrido P; López MN; Salazar-Onfray F
Clin Cancer Res; 2011 Apr; 17(8):2474-83. PubMed ID: 21292818
[TBL] [Abstract][Full Text] [Related]
39. Induction of Th1 response by dendritic cells pulsed with autologous melanoma apoptotic bodies.
Chang JW; Peng M; Vaquerano JE; Zhou YM; Clinton RA; Hyun WC; Giedlin MA; Leong SP
Anticancer Res; 2000; 20(3A):1329-36. PubMed ID: 10928040
[TBL] [Abstract][Full Text] [Related]
40. Dendritic cells prolong tumor-specific T-cell survival and effector function after interaction with tumor targets.
Mailliard RB; Lotze MT
Clin Cancer Res; 2001 Mar; 7(3 Suppl):980s-988s. PubMed ID: 11300500
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
